In addition, the expression changes and mutations in multiple GSTs were implicated to increase risks for aging-associated brain disorders associated with inflammation, such as Alzheimer’s disease (AD) (Piacentini et al., 2012; Liu et al., 2015; Wang et al., 2016; Jafarian et al., 2018). This evidence concerns the gene HPGDS and brain disorder.